September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
To help celebrate and recognize National Recovery Month, we have brought you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode and our discussion with Lyndra Bills, MD, senior medical director, and Shari Hutchison, MS, director of program evaluation and outcomes, both with Community Care Behavioral Health Organization, part of the UPMC Insurance Services Division.
More than 90% of adults have experienced a traumatic event at some point in their lifetime. Community Care Behavioral Health Organization has collaborated and continues to work, with county officials and health care providers to build a trauma-informed care network in rural Pennsylvania to address the demand for trauma-informed professionals. Evidence-based training programs have been developed in collaboration with the Behavioral Health Alliance of Rural Pennsylvania and a learning collaborative has been instrumental in facilitating culture change within provider practices. The success of these efforts is evident in their long-term sustainability, with providers maintaining trauma-informed practices, supported by ongoing training and learning initiatives.
Listen above or on one of these podcast services:
To listen to the other episodes in this series and to access exclusive companion video content, please visit our UPMC Health Plan partner page.
HS Treatment Goals: Better Quality of Life, Not Just Control
January 3rd 2025For part 3 of our discussion with Chris Sayed, MD, we tackle several important topics in the hidradenitis suppurative (HS) and inflammatory disease space: patient quality of life, medication and treatment goals, and the possibility of a cure.
Read More
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
Dr Yehuda Handelsman: DCRM Guidelines Are Shaping Integrated, Global CRM Care
January 3rd 2025In part 2 of our interview, Yehuda Handelsman, MD, discusses how cardiorenalmetabolic (CRM) disease management is advancing with the 2022 Diabetes, Cardiorenal, and Metabolic (DCRM) multispecialty practice recommendations and the updated DCRM 2.0 guidelines.
Read More